Suppr超能文献

患者自愈:利用患者来源的干细胞进行神经疾病建模和治疗。

Patient heal thyself: modeling and treating neurological disorders using patient-derived stem cells.

机构信息

Department of Neurology, Vanderbilt Kennedy Center, Vanderbilt Center for Stem Cell Biology, Vanderbilt Brain Institute, Vanderbilt University School of Medicine, Nashville, TN 37232, USA.

出版信息

Exp Biol Med (Maywood). 2013 Mar;238(3):308-14. doi: 10.1177/1535370213480713.

Abstract

Disorders of the brain and spinal cord are common worldwide problems but have remained very difficult to treat. As a group they have diverse etiologies and can be due to trauma, infection, tumors, genetic mutations and environmental insults. Though distinct in etiology, neurological disorders share an overall intractability as current therapies are largely limited to treatment of symptoms. Improved outcomes are further constrained by the minimal endogenous capacity of the brain and spinal cord for repair. Spectacular recent scientific advances, however, suggest that new stem cell-based approaches may change this undesirable situation. In this review, I will broadly outline the challenges of studying and treating disorders of the brain and spinal cord. I will review ongoing attempts to use stem cell-based therapies to both model and treat neurological disorders. While this field is in its infancy, expected advances and needed breakthroughs point to a future where patient-derived stem cells will be the basis for the emerging discipline of regenerative neurology.

摘要

脑和脊髓疾病是全球性的常见问题,但一直很难治疗。它们种类繁多,病因各异,可能由创伤、感染、肿瘤、基因突变和环境损伤等引起。尽管病因不同,但神经疾病的总体难治性相似,因为目前的治疗方法主要局限于症状治疗。由于大脑和脊髓的内源性修复能力有限,因此改善治疗效果受到进一步限制。然而,最近的科学进展表明,新的基于干细胞的方法可能会改变这种不理想的情况。在这篇综述中,我将广泛概述研究和治疗脑和脊髓疾病的挑战。我将回顾目前利用基于干细胞的疗法来模拟和治疗神经疾病的尝试。虽然这个领域还处于起步阶段,但预期的进展和需要的突破表明,未来患者来源的干细胞将成为再生神经科学这一新兴学科的基础。

相似文献

1
Patient heal thyself: modeling and treating neurological disorders using patient-derived stem cells.
Exp Biol Med (Maywood). 2013 Mar;238(3):308-14. doi: 10.1177/1535370213480713.
2
[Current status and perspective on regenerative medicine for spinal cord injury using iPS cell].
Rinsho Shinkeigaku. 2013;53(11):1013-5. doi: 10.5692/clinicalneurol.53.1013.
3
Human Pluripotent Stem Cells for Spinal Cord Injury.
Curr Stem Cell Res Ther. 2020;15(2):135-143. doi: 10.2174/1574362414666191018121658.
4
Therapeutic potential of human adipose-derived stem cells in neurological disorders.
J Pharmacol Sci. 2014;126(4):293-301. doi: 10.1254/jphs.14R10CP. Epub 2014 Nov 18.
5
Cell-based therapy approaches: the hope for incurable diseases.
Regen Med. 2014;9(5):649-72. doi: 10.2217/rme.14.35.
6
Recent advancements in stem cell and gene therapies for neurological disorders and intractable epilepsy.
Neuropharmacology. 2010 May;58(6):855-64. doi: 10.1016/j.neuropharm.2010.01.019. Epub 2010 Feb 8.
7
Stem Cell Transplantation: A Promising Therapy for Spinal Cord Injury.
Curr Stem Cell Res Ther. 2020;15(4):321-331. doi: 10.2174/1574888X14666190823144424.
10
The Application of Neural Stem/Progenitor Cells for Regenerative Therapy of Spinal Cord Injury.
Curr Stem Cell Res Ther. 2019;14(6):495-503. doi: 10.2174/1574888X14666190329095638.

引用本文的文献

1
Cellular reprogramming for understanding and treating human disease.
Front Cell Dev Biol. 2014 Nov 12;2:67. doi: 10.3389/fcell.2014.00067. eCollection 2014.
2
Potential for new medical countermeasures for radiation injury by targeting the Hedgehog signaling pathway.
Bone Marrow Transplant. 2014 Mar;49(3):321-3. doi: 10.1038/bmt.2013.203.

本文引用的文献

1
Somatic copy number mosaicism in human skin revealed by induced pluripotent stem cells.
Nature. 2012 Dec 20;492(7429):438-42. doi: 10.1038/nature11629. Epub 2012 Nov 18.
2
Mesenchymal stem cells as treatment for MS - progress to date.
Mult Scler. 2013 Apr;19(5):515-9. doi: 10.1177/1352458512464686. Epub 2012 Nov 1.
3
Preclinical research in Rett syndrome: setting the foundation for translational success.
Dis Model Mech. 2012 Nov;5(6):733-45. doi: 10.1242/dmm.011007.
4
Autologous mesenchymal stem cell therapy in progressive multiple sclerosis: an open label study.
Curr Stem Cell Res Ther. 2012 Nov;7(6):407-14. doi: 10.2174/157488812804484648.
5
Uncovering the neurobehavioural comorbidities of epilepsy over the lifespan.
Lancet. 2012 Sep 29;380(9848):1180-92. doi: 10.1016/S0140-6736(12)61455-X.
6
Directed differentiation of human pluripotent stem cells to cerebral cortex neurons and neural networks.
Nat Protoc. 2012 Oct;7(10):1836-46. doi: 10.1038/nprot.2012.116. Epub 2012 Sep 13.
8
Pharmacogenomics and personalized medicine in neuropsychiatry.
Neuron. 2012 Jun 7;74(5):773-6. doi: 10.1016/j.neuron.2012.05.004.
9
Neurodegeneration in ataxia telangiectasia: what is new? What is evident?
Neuropediatrics. 2012 Jun;43(3):119-29. doi: 10.1055/s-0032-1313915. Epub 2012 May 21.
10
Tumor heterogeneity and personalized medicine.
N Engl J Med. 2012 Mar 8;366(10):956-7. doi: 10.1056/NEJMe1200656.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验